Related Experiment Video
Updated: May 27, 2026

Molecular Imaging to Target Transplanted Muscle Progenitor Cells
Published on: March 27, 2013
[A experimental study on transfecting human stromal cell-derived factor 1alpha and human vascular endothelial growth
Dengqi He1, Xiufa Tang, Chengge Hua
1Department of Stomatology, First Hospital of Lanzhou University, Lanzhou Gansu 730000, PRChina.
Objective:
To explore the human stromal cell-derived factor 1alpha (hSDF-1alpha) and human vascular endothelial growth factor 165 (hVEGF165) mRNA expressions of the transfected cells after hSDF-1alpha gene and hVEGF165 gene were transfected into rat myoblasts in vitro so as to lay a foundation for further study on the synergistic effects of 2 genes on tissue engineered skeletal muscle vascularization.
Methods:
The myoblasts of 1-day-old Sprague Dawley rats were cultured and purified by trypsin digestion assay in vitro and were identified by immunohistochemistry staining of Desmin. Approximately 70%-80% of confluent myoblasts were transfected with enhanced green fluorescent protein (EGFP)-hSDF-1alpha and EGFP-hVEGF165 genes in vitro (transfected group) and were not transfected (control group). The expressions of hSDF-1alpha and hVEGF165 mRNA and protein in the transfected cells were detected by RT-PCR, ELISA, and Western blot respectively.
Results:
The cultured cells were identified as myoblasts by immunohistochemistry staining of Desmin. The expression of green fluorescent protein was observed in transfected cells, indicating that hSDF-1alpha and hVEGF165 genes were transfected into myoblasts successfully. The mRNA and protein expressions of the 2 genes were positive in the transfected group by RT-PCR and Western bolt assay at 2, 4, 6, and 8 days after transfection, and were negative in the control group. The expressions of hSDF-1alpha and hVEGF165 showed a stable low level in the control group, but the expressions of the proteins increased at 2 days and then showed gradual downtrend with time in the transfected group by ELISA assay. There were significant differences in the expressions of hSDF-1alpha and hVEGF165 proteins between different time points in the transfected group, and between 2 groups (P < 0.05).
Conclusion:
hSDF-1alpha and hVEGF165 genes are successfully transfected into myoblasts in vitro, and mRNA and proteins of hSDF-1alpha and hVEGF165 can be expressed in the transfected myoblasts, which may provide the experimental evidence for the expressions of hSDF-1alpha and hVEGF165 mRNA and proteins in vivo successfully.

